Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

HLA-DRA Antikörper

Der Maus Monoklonal anti-HLA-DRA Antikörper (Klon 19-26-1-same as MB-26-1) (ABIN6937414) detektiert spezifisch HLA-DRA in IHC, FACS und IF. Dieser Antikörper reagiert spezifisch mit Proben aus Human.
Produktnummer ABIN6937414
639,45 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 10 Werktagen

Kurzübersicht für HLA-DRA Antikörper (ABIN6937414)

Target

Alle HLA-DRA Antikörper anzeigen
HLA-DRA (HLA Class II DR alpha (HLA-DRA))

Reaktivität

  • 151
  • 18
  • 11
  • 10
  • 9
  • 9
  • 4
  • 3
  • 3
  • 1
Human

Wirt

  • 88
  • 77
  • 4
  • 1
  • 1
Maus

Klonalität

  • 101
  • 70
Monoklonal

Konjugat

  • 91
  • 13
  • 9
  • 6
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser HLA-DRA Antikörper ist unkonjugiert

Applikation

  • 80
  • 67
  • 53
  • 51
  • 25
  • 21
  • 13
  • 9
  • 9
  • 5
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunofluorescence (IF)

Klon

19-26-1-same as MB-26-1
  • Verwendungszweck

    HLA-DRA (MHC II) Antibody

    Spezifität

    This MAb reacts with the HLA-DR antigen, a member of MHC class II molecules. It does not cross react with HLA-DP and HLA-DQ. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36 kDa alpha (heavy) chain and a 28 kDa beta (light) chain. It is expressed on B-cells, activated T-cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 Molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. It is an excellent histiocytic marker in paraffin sections producing intense cytoplasmic staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Raji cells

    Isotyp

    IgG2a, kappa
  • Applikationshinweise

    Known_Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: Raji, Ramos, Daudi or HuT78 cells. Tonsil or lymph node.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Haltbarkeit

    24 months
  • Target

    HLA-DRA (HLA Class II DR alpha (HLA-DRA))

    Andere Bezeichnung

    HLA-DRA

    Hintergrund

    DR alpha chain, HLA class II histocompatibility antigen, HLA class II histocompatibility antigen DR alpha chain, HLA DRA, HLA DRA1, HLA-DRA, HLADRA1, Major histocompatibility complex class II DR alpha, MHC cell surface glycoprotein, MHC class II antigen DRA

    Daudi or HuT78 cells. Tonsil or lymph node., Raji, Ramos

    Molekulargewicht

    36kDa (α, chain) and 27kDa (β, chain)

    Gen-ID

    3122, 520048

    UniProt

    P01903

    Pathways

    T-Zell Rezeptor Signalweg, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Sie sind hier:
Chat with us!